- Filed
- Nov 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 14, 2025 | 2.85M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 2.09M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 1.2M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 576.77K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 533.51K sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$8.97M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$10.93M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $2.35M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.7M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$6.08M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$6.55M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$3.86M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$1.32M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $2.91M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $6.1M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $4.83M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $10.23M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $4.04M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $9.54M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $11.57M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $9.93M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $2.58M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $4.18M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $5.49M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $8.61M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.57 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$8.18 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$6.00 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$21.00 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.57 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$8.18 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$6.00 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$21.00 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.8M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $5.83M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $3.08M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $9.49M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $607K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $2.86M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $1.44M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $4.53M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$3.28M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$9.78M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$2.79M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$3.71M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$3.7M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$11.35M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$1.84M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$5.82M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$2.45M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$8.71M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$4.49M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$13.92M |
| Revenue | Q3 2025 · Sep 30, 2025 | $26K |
| Revenue | Q3 2025 · Sep 30, 2025 | $67K |
| Revenue | Q3 2025 · Sep 30, 2024 | $35K |
| Revenue | Q3 2025 · Sep 30, 2024 | $125K |
| Capex | Q3 2025 · Sep 30, 2024 | $18K |